Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1975 1
1979 1
1981 1
1982 1
1987 1
1989 2
1992 1
1995 2
1996 5
1997 2
1998 1
1999 1
2000 5
2001 1
2002 7
2003 6
2004 3
2005 4
2006 5
2007 7
2008 3
2009 7
2010 1
2011 3
2012 5
2013 6
2014 6
2015 3
2016 5
2017 11
2018 7
2019 7
2020 10
2021 13
2022 12
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Nephrotic syndrome, type 11"
Page 1
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.
Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ. Beck LH Jr, et al. N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457. N Engl J Med. 2009. PMID: 19571279 Free PMC article.
BACKGROUND: Idiopathic membranous nephropathy, a common form of the nephrotic syndrome, is an antibody-mediated autoimmune glomerular disease. ...Mass spectrometry of the reactive protein band detected the M-type phospholipase A(2) receptor (PLA(2)R). Reactiv …
BACKGROUND: Idiopathic membranous nephropathy, a common form of the nephrotic syndrome, is an antibody-mediated autoimmune glo …
What is circulating factor disease and how is it currently explained?
Hayward S, Parmesar K, Saleem MA. Hayward S, et al. Pediatr Nephrol. 2023 Nov;38(11):3513-3518. doi: 10.1007/s00467-023-05928-8. Epub 2023 Mar 23. Pediatr Nephrol. 2023. PMID: 36952039 Free PMC article. Review.
Nephrotic syndrome (NS) consists of the clinical triad of hypoalbuminaemia, high levels of proteinuria and oedema, and describes a heterogeneous group of disease processes with different underlying drivers. ...Several circulating factors have been proposed and studi …
Nephrotic syndrome (NS) consists of the clinical triad of hypoalbuminaemia, high levels of proteinuria and oedema, and describ …
Sphingosine phosphate lyase insufficiency syndrome: a systematic review.
Pournasiri Z, Madani A, Nazarpack F, Sayer JA, Chavoshzadeh Z, Nili F, Tran P, Saba JD, Jamee M. Pournasiri Z, et al. World J Pediatr. 2023 May;19(5):425-437. doi: 10.1007/s12519-022-00615-4. Epub 2022 Nov 12. World J Pediatr. 2023. PMID: 36371483 Review.
BACKGROUND: Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) or nephrotic syndrome type-14 is caused by biallelic mutations in SGPL1. ...Kidney disorders (42, 80.8%) were mainly in the form of steroid-resistant nephrotic syndrome …
BACKGROUND: Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS) or nephrotic syndrome type-14 is caused …
Treatment and outcome of congenital nephrotic syndrome.
Bérody S, Heidet L, Gribouval O, Harambat J, Niaudet P, Baudouin V, Bacchetta J, Boudaillez B, Dehennault M, de Parscau L, Dunand O, Flodrops H, Fila M, Garnier A, Louillet F, Macher MA, May A, Merieau E, Monceaux F, Pietrement C, Rousset-Rouvière C, Roussey G, Taque S, Tenenbaum J, Ulinski T, Vieux R, Zaloszyc A, Morinière V, Salomon R, Boyer O. Bérody S, et al. Nephrol Dial Transplant. 2019 Mar 1;34(3):458-467. doi: 10.1093/ndt/gfy015. Nephrol Dial Transplant. 2019. PMID: 29474669
BACKGROUND: Recommendations for management of Finnish-type congenital nephrotic syndrome (CNS) followed by many teams include daily albumin infusions, early bilateral nephrectomy, dialysis and transplantation. ...Thirty-nine patients reached end-stage kidney …
BACKGROUND: Recommendations for management of Finnish-type congenital nephrotic syndrome (CNS) followed by many teams i …
Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Podocytes in Mouse Nephrotic Syndrome.
Suzuki T, Iyoda M, Kanazawa N, Tachibana S, Honda H. Suzuki T, et al. Lab Invest. 2023 Sep;103(9):100199. doi: 10.1016/j.labinv.2023.100199. Epub 2023 Jun 16. Lab Invest. 2023. PMID: 37331628
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is known to play a crucial role in dyslipidemia, and an increase in serum PCSK9 levels has also been reported in patients with nephrotic syndrome (NS). ...Male BALB/c mice were divided into the following 4 …
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is known to play a crucial role in dyslipidemia, and an increase in serum PCSK9 …
Cholelithiasis in infants with congenital nephrotic syndrome of the Finnish type.
Nada T, Sato M, Yoshikawa T, Ogura M, Kamei K. Nada T, et al. Pediatr Nephrol. 2021 Nov;36(11):3795-3798. doi: 10.1007/s00467-021-05225-2. Epub 2021 Aug 12. Pediatr Nephrol. 2021. PMID: 34383124
BACKGROUND: Congenital nephrotic syndrome of the Finnish type (CNF) caused by NPHS1 mutations is a rare disease. ...
BACKGROUND: Congenital nephrotic syndrome of the Finnish type (CNF) caused by NPHS1 mutations is a rare disease. ...
Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.
Van Horebeek I, Knops N, Van Dyck M, Levtchenko E, Mekahli D. Van Horebeek I, et al. Acta Clin Belg. 2017 Jun;72(3):147-155. doi: 10.1080/17843286.2016.1208955. Epub 2016 Jul 13. Acta Clin Belg. 2017. PMID: 27409338 Review.
OBJECTIVES: Rituximab (RTX) is a new treatment option in children with difficult-to-treat steroid-dependent nephrotic syndrome (SDNS). We evaluated the experience of our tertiary center and reviewed the current literature. ...RESULTS: Nine children with a median age …
OBJECTIVES: Rituximab (RTX) is a new treatment option in children with difficult-to-treat steroid-dependent nephrotic syndrome …
A cross-sectional nationwide survey of congenital and infantile nephrotic syndrome in Japan.
Hamasaki Y, Hamada R, Muramatsu M, Matsumoto S, Aya K, Ishikura K, Kaneko T, Iijima K. Hamasaki Y, et al. BMC Nephrol. 2020 Aug 24;21(1):363. doi: 10.1186/s12882-020-02010-5. BMC Nephrol. 2020. PMID: 32838745 Free PMC article.
BACKGROUND: Congenital nephrotic syndrome (CNS) and infantile nephrotic syndrome (INS) cause substantial morbidity and mortality. ...Among those with non-Finnish-type disease, 26 had no syndrome and 24 had a syndrome, of which the …
BACKGROUND: Congenital nephrotic syndrome (CNS) and infantile nephrotic syndrome (INS) cause substantial morbidi …
Type I membranoproliferative glomerulonephritis and HCV infection.
Rostoker G, Pawlotsky JM, Bastie A, Weil B, Dhumeaux D. Rostoker G, et al. Nephrol Dial Transplant. 1996;11 Suppl 4:22-4. doi: 10.1093/ndt/11.supp4.22. Nephrol Dial Transplant. 1996. PMID: 8918747 Review.
MPGN are thought to be linked to the deposition of immune complexes preformed in the circulation or formed in situ in the glomeruli. A link between HCV and type I MPGN was reported for the first time in 1993. In some patients, the renal clinical pattern is the most obvious …
MPGN are thought to be linked to the deposition of immune complexes preformed in the circulation or formed in situ in the glomeruli. A link …
Pathogenesis of membranous nephropathy: update.
Kwatra IS, Prasher PK. Kwatra IS, et al. J Assoc Physicians India. 2013 Nov;61(11):807-10. J Assoc Physicians India. 2013. PMID: 24974493 Review.
Membranous nephropathy (MN) is the most common cause of adult nephrotic syndrome and it accounts for about 25% of renal biopsies done for this syndrome. ...Role of in situ formation of immune complexes and involvement of complement system was established. Rec …
Membranous nephropathy (MN) is the most common cause of adult nephrotic syndrome and it accounts for about 25% of renal biopsi …
144 results